Cullinan Therapeutics (NASDAQ:CGEM) just disclosed its Q4 earnings on Tuesday, March 10, 2026 at 07:00 AM.
Here’s a brief overview of the earnings report.
Earnings
Cullinan Therapeutics beat estimated earnings by 6.1%, reporting an EPS of $-0.77 versus an estimate of $-0.82.
Revenue was down $0 from the same period last year.
Past Earnings Performance
During the previous quarter, the …